The Effect of n-3 Polyunsaturated Fatty Acids in Patients With Psoriatic Arthritis
|ClinicalTrials.gov Identifier: NCT01818804|
Recruitment Status : Completed
First Posted : March 27, 2013
Last Update Posted : February 18, 2016
Information provided by (Responsible Party):
Salome Kristensen, Aalborg Universitetshospital
Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
|Recruitment Status :||Completed|
|Primary Completion Date :||December 2015|
|Study Completion Date :||December 2015|
|Submission Cycle||Results Submitted to ClinicalTrials.gov||Results Returned after Quality Control Review|
|1||February 8, 2018|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Kristensen S, Schmidt EB, Schlemmer A, Rasmussen C, Lindgreen E, Johansen MB, Christensen JH. The effect of marine n-3 polyunsaturated fatty acids on cardiac autonomic and hemodynamic function in patients with psoriatic arthritis: a randomised, double-blind, placebo-controlled trial. Lipids Health Dis. 2016 Dec 12;15(1):216.